The Experts below are selected from a list of 9 Experts worldwide ranked by ideXlab platform
Nicholson J - One of the best experts on this subject based on the ideXlab platform.
-
Nasogastric Drug Administration.
Professional nurse (London England), 1998Co-Authors: Nicholson JAbstract:Nurses working in one trust frequently requested advice on the preparation of Drugs for Nasogastric Administration, prompting a survey of their knowledge in this area. As a result, guidelines were prepared to aid nurses and alert them to potential problems.
C Juez Santamaría - One of the best experts on this subject based on the ideXlab platform.
-
3PC-016 Implementation of new recommendations for handling hazardous Drugs
Section 3: Production and compounding, 2018Co-Authors: Mh García Lagunar, M Martínez Penella, Mc Mira Sirvent, Am Chica Marchal, I Muñoz García, Ac Viney, E Conesa Nicolás, S Nuñez Bracamonte, A Lloret Llorca, C Juez SantamaríaAbstract:Background Some Drugs can be considered hazardous because of their potential to cause irreversible effects. Purpose To describe the actions carried out in a pharmacy service after the publication of Spanish National Institute of Occupational Health and Safety (INSHT) recommendations about hazardous Drugs (HD). Material and methods A list with the HD included in the pharmacotherapeutic guide was drawn up. HD were classified according to the requirements when handling them and actions about their storage, repackaging, preparation and dispensation needed. The pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were updated. The actions carried out were communicated to the Hospital’s management team and nursing staff. Results Of the 321 pharmaceutical forms included in the INSHT list, 134 were excluded (not included in the pharmacotherapeutic guide) and four were withdrawn from the guide because of the low level of consumption. The 183 Drugs included were classified as: 101 from group 1, 44 from group 2 and 38 from group 3. The HD were classified according to the actions carried out in six groups: 64 parenteral antineoplastic Drugs which are prepared in a class IIb Biological Safety Cabinet (IIb–BSC). 40 oral antineoplastic Drugs for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. Nursing staff should contact the pharmacy service to assess that the treatment is temporarily stopped, administered via another route or split in a IIb–BSC. 15 Drugs that do not require any manipulation to compound them (pre–filled syringes, ointments, vaginal tablets and oral solutions). 47 oral Drugs (groups 2 and 3) for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. 10 Drugs that must be reconstituted in a IIb–BSC. 7 parenteral Drugs with recommendations only if the handler is at reproductive risk. Furthermore, the repackaging process of five Drugs and the Standard Operating Procedures of five compounded medications were modified to be carried out inside the IIb-BSC. Conclusion The actions adopted have supposed a decrease in the risk of occupational exposure in nursing staff, minimising the handling of HD with a consequent increase in safety. These modifications have led to an increase in the workload of the pharmacy service. References and/or Acknowledgements INSHT recommendations about Hazardous Drugs. 2017. No conflict of interest
Mh García Lagunar - One of the best experts on this subject based on the ideXlab platform.
-
3PC-016 Implementation of new recommendations for handling hazardous Drugs
Section 3: Production and compounding, 2018Co-Authors: Mh García Lagunar, M Martínez Penella, Mc Mira Sirvent, Am Chica Marchal, I Muñoz García, Ac Viney, E Conesa Nicolás, S Nuñez Bracamonte, A Lloret Llorca, C Juez SantamaríaAbstract:Background Some Drugs can be considered hazardous because of their potential to cause irreversible effects. Purpose To describe the actions carried out in a pharmacy service after the publication of Spanish National Institute of Occupational Health and Safety (INSHT) recommendations about hazardous Drugs (HD). Material and methods A list with the HD included in the pharmacotherapeutic guide was drawn up. HD were classified according to the requirements when handling them and actions about their storage, repackaging, preparation and dispensation needed. The pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were updated. The actions carried out were communicated to the Hospital’s management team and nursing staff. Results Of the 321 pharmaceutical forms included in the INSHT list, 134 were excluded (not included in the pharmacotherapeutic guide) and four were withdrawn from the guide because of the low level of consumption. The 183 Drugs included were classified as: 101 from group 1, 44 from group 2 and 38 from group 3. The HD were classified according to the actions carried out in six groups: 64 parenteral antineoplastic Drugs which are prepared in a class IIb Biological Safety Cabinet (IIb–BSC). 40 oral antineoplastic Drugs for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. Nursing staff should contact the pharmacy service to assess that the treatment is temporarily stopped, administered via another route or split in a IIb–BSC. 15 Drugs that do not require any manipulation to compound them (pre–filled syringes, ointments, vaginal tablets and oral solutions). 47 oral Drugs (groups 2 and 3) for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. 10 Drugs that must be reconstituted in a IIb–BSC. 7 parenteral Drugs with recommendations only if the handler is at reproductive risk. Furthermore, the repackaging process of five Drugs and the Standard Operating Procedures of five compounded medications were modified to be carried out inside the IIb-BSC. Conclusion The actions adopted have supposed a decrease in the risk of occupational exposure in nursing staff, minimising the handling of HD with a consequent increase in safety. These modifications have led to an increase in the workload of the pharmacy service. References and/or Acknowledgements INSHT recommendations about Hazardous Drugs. 2017. No conflict of interest
H Karaca - One of the best experts on this subject based on the ideXlab platform.
-
PS-066 Reviewing the appropriateness of the oral Drugs administered via Nasogastric tube in intensive care units
European Journal of Hospital Pharmacy, 2014Co-Authors: M Ulgey, E Guner, D Turktas, F Karaoglu, B Sanliturk, S Donmez, H KaracaAbstract:Background Reviewing the patient charts, our department realised the inappropriateness of some oral Drugs that were being administered via Nasogastric tube. We discovered the need to conduct a study that would examine the positive impact of pharmacy analysis of intensive care unit cases where Nasogastric Drug Administration is necessary and liaison with physicians to improve outcomes. Purpose To report acceptability of the Drugs administered to the patients via Nasogastric tube in an intensive care unit and ensure patients experienced the precise effect that physicians wanted to get from the treatment. Materials and methods Patient charts were evaluated daily, using the computer system. In the first period of the study, pharmacists prepared recommendations regarding improved practice for Nasogastric Administration of Drugs. Between the two study periods, a meeting was arranged with doctors and a consensus was reached for a preferred approach in future. At the end of the second period, our department shared the results with the participating doctors. Results During 1 month, 558 patient charts were evaluated. While in the first period, the average rate of patients who are using inappropriate Drugs was 51% and the number of inappropriate Drugs per patient was 0.73; in the second period the results under the same categories were 9% (82.35% reduction) and 0.09 (87.67% reduction), respectively. Suggestions regarding the inappropriate oral Drugs identified were: changing the pharmaceutical form (52%) and using a different Drug from the same pharmacological group (40%). We couldn’t make suggestion for 8% of the cases due to a lack of suitable medicines in our pharmacy’s Drug reserve. Physicians implemented 86.95% of our suggestions. Conclusions We recommend similar studies by hospital pharmacies that provide medicines to intensive care units as one of the best ways to raise the ward’s standard of Drug care. No conflict of interest.
Am Chica Marchal - One of the best experts on this subject based on the ideXlab platform.
-
3PC-016 Implementation of new recommendations for handling hazardous Drugs
Section 3: Production and compounding, 2018Co-Authors: Mh García Lagunar, M Martínez Penella, Mc Mira Sirvent, Am Chica Marchal, I Muñoz García, Ac Viney, E Conesa Nicolás, S Nuñez Bracamonte, A Lloret Llorca, C Juez SantamaríaAbstract:Background Some Drugs can be considered hazardous because of their potential to cause irreversible effects. Purpose To describe the actions carried out in a pharmacy service after the publication of Spanish National Institute of Occupational Health and Safety (INSHT) recommendations about hazardous Drugs (HD). Material and methods A list with the HD included in the pharmacotherapeutic guide was drawn up. HD were classified according to the requirements when handling them and actions about their storage, repackaging, preparation and dispensation needed. The pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were updated. The actions carried out were communicated to the Hospital’s management team and nursing staff. Results Of the 321 pharmaceutical forms included in the INSHT list, 134 were excluded (not included in the pharmacotherapeutic guide) and four were withdrawn from the guide because of the low level of consumption. The 183 Drugs included were classified as: 101 from group 1, 44 from group 2 and 38 from group 3. The HD were classified according to the actions carried out in six groups: 64 parenteral antineoplastic Drugs which are prepared in a class IIb Biological Safety Cabinet (IIb–BSC). 40 oral antineoplastic Drugs for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. Nursing staff should contact the pharmacy service to assess that the treatment is temporarily stopped, administered via another route or split in a IIb–BSC. 15 Drugs that do not require any manipulation to compound them (pre–filled syringes, ointments, vaginal tablets and oral solutions). 47 oral Drugs (groups 2 and 3) for which the pharmacotherapeutic guide and the guidelines for Nasogastric Drug Administration were modified to avoid splitting or crushing. 10 Drugs that must be reconstituted in a IIb–BSC. 7 parenteral Drugs with recommendations only if the handler is at reproductive risk. Furthermore, the repackaging process of five Drugs and the Standard Operating Procedures of five compounded medications were modified to be carried out inside the IIb-BSC. Conclusion The actions adopted have supposed a decrease in the risk of occupational exposure in nursing staff, minimising the handling of HD with a consequent increase in safety. These modifications have led to an increase in the workload of the pharmacy service. References and/or Acknowledgements INSHT recommendations about Hazardous Drugs. 2017. No conflict of interest
